Relapsed or Refractory Advanced Cancer
1 clinical trials · Condition
◉ Watch Relapsed or Refractory Advanced Cancer
| Record | Firm | Date |
|---|---|---|
| Effect of Ridaforolimus on the Pharmacokinetics of Midazolam (Study MK-8669-044) (NCT01071304) | Merck Sharp & Dohme LLC | 2010-03-01 |
Track Relapsed or Refractory Advanced Cancer automatically
Every clearance here is in the API, with alerts when new ones post.